Product Code: RP-ID-10293958 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10293958
Market Overview:
Oxygen Therapy Market, By types (Oxygen Source and Oxygen Delivery Devices), by application(Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Pneumonia and others), by end user (hospitals, and home healthcare) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025
REPORT HIGHLIGHT
The oxygen therapy market is estimated to represent a global market of USD 17.6 billion by 2025 with growth rate of 9.9%. Oxygen therapy devices are used to provide supplemental oxygen to the patients in medical conditions. As per the many respiratory therapies, oxygen therapy devices are most useful medical devices in healthcare setting and is much needed medical devices in hospital settings. Increasing incidence of respiratory disorders have stimulated the demand for oxygen devices across the globe.
The market is majorly categorized into products such as Oxygen Source and Oxygen Delivery Devices. Oxygen source devices categorized into Positive Airway Pressure (PAP) Devices, Oxygen Cylinders, Oxygen Concentrators, and Liquid Oxygen Devices. Among which, we estimated that PAP devices contributed around 16.23% share of the total market in 2016 which was the lowest compared to other segment. Availability of alternative devices coupled with huge competition in this product segment is projected to pull back the segment growth.
Oxygen delivery devices is divided into Oxygen Masks, Venturi Masks, Non-rebreather Masks, Bag Valve Masks and others. Oxygen masks are the highest revenue generating segment, followed by the venturi masks. High demand coupled with advancement in technologies have surged the uptake of these products, leading to the market growth. For example, CareFusion offer AirLife disposable oxygen masks which is latex-free and made from soft , high-grade vinyl resins. The smooth, and feathered edges device is designed for anatomical compatibility. Thus, provide superior patient comfort and reduce irritation points.
The market is further studied based on various applications of oxygen therapy devices such as for Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Pneumonia and others. Use of oxygen therapy devices for COPD and asthma is fast catching up and captured more than 65% share of the total market revenue. End user segment is divided into hospital and home healthcare field. Among which, we understood that the oxygen therapy devices is most prominent and widely used in home healthcare sector compared to the hospital facilities. Home healthcare captured almost 60% share of the global market revenue.
Geographically, North America captured 40.12% share of the global market in 2016. Increasing incidence of respiratory disorders is considered to be the primary driver for the market growth. According to Centers for Disease Control and Prevention (CDC), there were approximately 12.7 million adults aged over 18 reported to have COPD in the U.S. Regions such as Asia Pacific and Latin America is growing with the highest growth rate. Government initiatives coupled with growing demand for oxygen devices support the market demand.
Key players such as BiognostiX, Navigene Genetic Science Pvt Ltd., Micro Essential Labs, Kenosha C.V., GVS Filter Technology Inc., Alere, Diagnostics for All, Inc. and Bio-Rad Laboratories are present in this market. Among which, Diagnostics for All, Inc. and BiognostiX are accounted for the highest share of the market, captured more than 35% share in 2016. Strategic alliance and expanding product portfolio in oxygen therapy segment helped these companies to enhance its customer bases hence supported the revenue growth.
The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.
The years considered for the study are:
Historical Year – 2014 & 2015
Base Year – 2015
Estimated Year – 2016
Projected Year – 2025
TARGET AUDIENCE
Traders, Distributors, And Suppliers
Hospitals
Manufacturers
Government and Regional Agencies and Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY TYPES
Oxygen Source Devices
Positive Airway Pressure (PAP) Devices
Oxygen Cylinders
Oxygen Concentrators
Liquid Oxygen Devices
Oxygen Delivery Devices
Oxygen Masks
Venturi Masks
Non-rebreather Masks
Bag Valve Masks
others
MARKET, BY APPLICATION
Chronic Obstructive Pulmonary Disease
Asthma
Obstructive Sleep Apnea
Respiratory Distress Syndrome
Pneumonia
others
MARKET, BY END USE
Hospitals
Home Healthcare
MARKET, BY REGION
North America
Europe
Asia Pacific
Rest of the World
MARKET, BY COUNTRY
Further Breakdown of The North America Market
U.S.
Canada
Further Breakdown of The Europe Market
Germany
France
Rest of Europe
Further Breakdown of The APAC Market
India
China
Rest of APAC
Further Breakdown of The Rest of the World Market
Middle-East and Africa
Latin America
Related Reports
Proof of Quality & Reliability
